Summary:
Clinical research study of an investigational medication for the treatment of moderately to severe active Crohn's disease.
Qualified Participants Must:
Diagnosed with Crohn's disease for at least 3 months
Have been previously or currently treated for Crohn's
Qualified Participants May Receive:
- All study medication and procedures at no cost
- Compensation for time and travel